BeOne Medicines Italia appoints Silvia Morandotti as Director of Business Operations & Excellence

BeOne Medicines Italia has appointed Silvia Morandotti as the new Director of Business Operations & Excellence. Morandotti has been with the company since 2023, previously managing the Business Operations team while maintaining responsibility for Regulatory, Quality, and Compliance functions.

With over twenty years of experience in the pharmaceutical sector, Morandotti’s career includes roles in clinical research, regulatory affairs, and pharmacovigilance. Prior to joining BeOne Medicines Italia, she held positions at Swedish Orphan Biovitrum, Celgene, and Amgen.

The creation of this new role is part of a strategic effort by BeOne Medicines Italia to strengthen its organizational model and operational excellence. General Manager and CEO Marco Sartori stated that the appointment supports the company’s growth and evolution within the Italian market.